Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD
Authors:
- Ming-Fang WuMWMing-Fang Wu
- Zhi-Hong JianZJZhi-Hong Jian
- Jing-Yang HuangJHJing-Yang Huang
- Cheng-Feng JanCJCheng-Feng Jan
- Oswald Ndi NforONOswald Ndi Nfor
- Kai-Ming JhangKJKai-Ming Jhang
- Wen-Yuan KuWKWen-Yuan Ku
- Chien-Chang HoCHChien-Chang Ho
- Chia-Chi LungCLChia-Chi Lung
- Hui-Hsien PanHPHui-Hsien Pan
- Min-Chen WuMWMin-Chen Wu
- Yung-Po LiawYLYung-Po Liaw
Open Access
- 10 October 2016
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 778
Abstract
Inhaled corticosteroids (ICS) have been associated with decreased lung cancer risk. However, they have been associated with pulmonary infections (tuberculosis [TB] and pneumonia) in patients with chronic obstructive pulmonary disease (COPD). TB and pneumonia have increased lung cancer risk. The association between post-ICS pulmonary infections and lung cancer remains unclear. We conducted a retrospective cohort study from 2003 to 2010 using the Taiwan National Health Insurance Research Database. Among the 1,089,955 patients with COPD, we identified 8813 new users of ICS prescribed for a period of 3 months or more and 35,252 non-ICS users who were randomly matched for sex, age and date of ICS use from 2003 to 2005. Cox proportional hazard regression was used to estimate the hazard ratio (HR) of pulmonary infections in patients with/without ICS use. The HRs for lung cancer in ICS users with sequential lung infections were as follows; 2.42 (95 % confidence interval [CI], 1.28–4.58) for individuals with TB, 2.37 (95 % CI, 1.01–5.54) for TB and pneumonia, and 1.17(95 % CI, 0.69–1.98) for those with pneumonia. For non-ICS users with pulmonary infections, the HRs were 1.68 (95 % CI, 0.78–3.65) for individual with TB and pneumonia, 1.42 (95 % CI, 0.89–2.26) for TB, and 0.95 (95 % CI, 0.62–1.46) for individuals with pneumonia. COPD patients with TB /or pneumonia who used ICS had increased risk of lung cancer. Because the overall prognosis of lung cancer remains poor, screening tests are recommended for patients with these conditions.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy and safety of inhaled and intranasal corticosteroids.Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2014
- Inhaled corticosteroids and the increased risk of pulmonary tuberculosis: a population-based case-control studyInternational Journal Of Clinical Practice, 2014
- The Role of Inflammation in Lung Cancer2014
- Use of inhaled corticosteroids and the risk of tuberculosisThorax, 2013
- Inhaled corticosteroids for stable chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2012
- Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort StudyJournal of Thoracic Oncology, 2011
- Pulmonary tuberculosis increases the risk of lung cancerCancer, 2010
- Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case–control studyLung Cancer, 2010
- Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and futureEuropean Journal of Clinical Pharmacology, 2009
- Low Lung Function and Incident Lung Cancer in the United StatesArchives of internal medicine (1960), 2003